Freitag Gregory Gene — SEC Form 4 filings
SEC reporting owner CIK 1492710. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-08 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 15,060 shares, $25,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 25,000 shares, $225,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 25,000 shares @ $9.00 ($225,000) in Axogen, Inc., filed 2024-03-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Axogen, Inc. (AXGN) | Director | 2 | — | 1 leg · 25,000 sh · $225,000 | 2 |
| PDS Biotechnology Corp (PDSB) | Director | 4 | 1 leg · 15,060 sh · $25,000 | — | 4 |
| ZyVersa Therapeutics, Inc. (ZVSA) | Director | 2 | — | — | 2 |
Form 4 filings — Freitag Gregory Gene
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | PDS Biotechnology Corp (PDSB) | Grant/award (A): 54,876 (derivative) @ $0 | EDGAR |
| 2025-07-15 | 4 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/award (A): 11,066 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | PDS Biotechnology Corp (PDSB) | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | PDS Biotechnology Corp (PDSB) | Purchase (P): 15,060 @ $1.66 · Purchase (P): 15,060 (derivative) | EDGAR |
| 2024-07-18 | 4 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/award (A): 132 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | PDS Biotechnology Corp (PDSB) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Axogen, Inc. (AXGN) | Option exercise (M): 11,904 @ $0 · Option exercise (M): 11,904 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Axogen, Inc. (AXGN) | Sale (S): 25,000 @ $9 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1492710 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →